IDEXX stock price target raised to $530 at BTIG
BTIG analyst Mark Massaro announced an increased price target for IDEXX Laboratories (NASDAQ:IDXX), raising it from $500 to $530, while maintaining a Buy rating on the stock. The revision follows ...
TMCnet17h
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
BTIG is a leading global financial services firm specializing in investment banking, institutional trading, research, and ...
TMCnet18h
InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
For more information about the event, visit InMode's investor relations site here.
BTIG Keeps Their Buy Rating on DraftKings (DKNG)
In a report released today, Clark Lampen from BTIG maintained a Buy rating on DraftKings (DKNG – Research Report), with a price target of ...
MGM Resorts downgraded to Neutral at BTIG, sees shares rangebound
BTIG downgraded MGM Resorts (MGM) to Neutral from Buy ahead of the Q4 earnings report. The firm is optimistic around iGaming market expansion, ...
BTIG Research Estimates D.R. Horton’s Q4 Earnings (NYSE:DHI)
Research analysts at BTIG Research reduced their Q4 2025 earnings estimates for shares of D.R. Horton in a research note ...
BTIG maintains neutral PayPal stock rating amid growth concerns
BTIG analyst Lance Jessurun reaffirmed a Neutral rating on PayPal (NASDAQ:PYPL) stock, expressing caution ahead of the ...